HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

L Kang Selected Research

Mannitol (Osmitrol)

7/2007Significantly increased lifespan and improved behavioral performances by rAAV gene delivery in adult mucopolysaccharidosis IIIB mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


L Kang Research Topics

Disease

5Neoplasms (Cancer)
06/2021 - 05/2015
4Rectal Neoplasms (Rectal Cancer)
11/2022 - 05/2015
2Stroke (Strokes)
04/2023 - 11/2005
2Neoplasm Metastasis (Metastasis)
11/2022 - 06/2021
2Colorectal Neoplasms (Colorectal Cancer)
06/2021 - 09/2014
2Hemorrhage
06/2021 - 08/2019
2Cognitive Dysfunction
01/2021 - 01/2019
2Uterine Cervical Neoplasms (Cancer of the Cervix)
05/2016 - 01/2016
1Short Bowel Syndrome
03/2024
1Intestinal Failure
03/2024
1Abscess
07/2022
1Hernia (Hernias)
07/2022
1Anastomotic Leak
06/2021
1Infections
06/2021
1Intestinal Obstruction (Obstruction, Intestinal)
06/2021
1COVID-19
04/2021
1Bronchopulmonary Dysplasia
12/2019
1Newborn Respiratory Distress Syndrome
12/2019
1Flatulence
08/2019
1Urinary Bladder Neoplasms (Bladder Cancer)
04/2017
1Hypoxia (Hypoxemia)
01/2017
1Osteoarthritis
12/2015
1Fecal Incontinence
09/2015
1Heroin Dependence (Heroin Abuse)
01/2015
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
05/2014
1Leukemia
05/2014
1Insulin Resistance
03/2013
1Neuroinflammatory Diseases
06/2011
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
06/2011
1Necrosis
03/2011
1Insulinoma
03/2011
1Migraine Disorders (Migraine)
04/2008
1Lysosomal Storage Diseases (Lysosomal Storage Disease)
07/2007
1Mucopolysaccharidoses
07/2007
1Mucopolysaccharidosis III (Sanfilippo Syndrome)
07/2007
1Brain Infarction
07/2000
1Brain Ischemia (Cerebral Ischemia)
07/2000

Drug/Important Bio-Agent (IBA)

2Paclitaxel (Taxol)FDA LinkGeneric
05/2016 - 01/2016
1salicylhydroxamic acid (SHAM)IBA
04/2023
1Texas redIBA
04/2023
1Dextrans (Dextran)FDA Link
04/2023
1MucinsIBA
11/2022
13,4- dihydroxy- 3,4- dihydro- 7- ethylbenz(a)anthracene (EBAD)IBA
07/2022
1AerosolsIBA
04/2021
1acetovanillone (apocynin)IBA
01/2021
1Budesonide (Pulmicort)FDA LinkGeneric
12/2019
1poractant alfa (Curosurf)FDA Link
12/2019
1Sirtuin 1IBA
12/2019
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2017
1Transcription Factors (Transcription Factor)IBA
01/2017
1Metalloproteases (Metalloproteinases)IBA
12/2015
1DisintegrinsIBA
12/2015
1Proteins (Proteins, Gene)FDA Link
12/2015
1ThrombospondinsIBA
12/2015
1Dexamethasone (Maxidex)FDA LinkGeneric
05/2015
1Immunoglobulin M (IgM)IBA
01/2015
1Heroin (Diamorphine)IBA
01/2015
1Immunoglobulin G (IgG)IBA
01/2015
1RNA (Ribonucleic Acid)IBA
05/2014
1Doxycycline (Periostat)FDA LinkGeneric
05/2014
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
03/2013
1LipidsIBA
03/2013
1AMP-Activated Protein KinasesIBA
03/2013
1scutellarinIBA
06/2011
1PalmitatesIBA
03/2011
1TunicamycinIBA
03/2011
1CytokinesIBA
03/2011
1ThapsigarginIBA
03/2011
1InterleukinsIBA
03/2011
1InterferonsIBA
03/2011
1Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
03/2011
1sodium bisulfide (NaHS)IBA
03/2011
1erucylphosphocholineIBA
04/2008
1Mannitol (Osmitrol)FDA LinkGeneric
07/2007
1alpha-N-acetyl-D-glucosaminidase (alpha-N-acetylglucosaminidase)IBA
07/2007
1Complement System Proteins (Complement)IBA
07/2007
1Apolipoproteins E (ApoE)IBA
11/2005
1E2F1 Transcription FactorIBA
07/2000

Therapy/Procedure

2Ileostomy
06/2021 - 09/2015
2Neoadjuvant Therapy
06/2021 - 08/2019
2Therapeutics
06/2021 - 09/2014
1Nutritional Support (Artificial Feeding)
03/2024
1Chemoradiotherapy
11/2022
1Catheters
07/2022
1Radiotherapy
06/2021
1Colectomy
11/2020
1Conservative Treatment
08/2019
1Lymph Node Excision (Lymph Node Dissection)
08/2019
1Length of Stay
08/2019
1Activities of Daily Living (ADL)
01/2019